89
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Development and Evaluation of a New Predictive Nomogram for Predicting Risk of Herpes Zoster Infection in a Chinese Population with Type 2 Diabetes Mellitus

ORCID Icon, , , , , , ORCID Icon, & ORCID Icon show all
Pages 4789-4797 | Published online: 27 Nov 2021

References

  • Saadatian-Elahi M, Bauduceau B, Del-Signore C, et al. Diabetes as a risk factor for herpes zoster in adults: a synthetic literature review. Diabetes Res Clin PR. 2020;159:107983. doi:10.1016/j.diabres.2019.107983
  • Johnson RW, Rice AS, Solomon CG. Clinical practice. Postherpetic neuralgia. N Engl J Med. 2014;371(16):1526–1533. doi:10.1056/NEJMcp1403062
  • El KM, Wifi MN, Mahdy R, et al. Herpes Zoster reactivation in patients with chronic hepatitis C under treatment with directly acting antiviral agents: a case series. Arab J Gastroenterol. 2017;18(1):39–41. doi:10.1016/j.ajg.2017.02.003
  • Bonanni P, Breuer J, Gershon A, et al. Varicella vaccination in Europe - taking the practical approach. BMC Med. 2009;7:26. doi:10.1186/1741-7015-7-26
  • Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087–2096. doi:10.1056/NEJMoa1501184
  • Gater A, Uhart M, McCool R, et al. The humanistic, economic and societal burden of herpes zoster in Europe: a critical review. BMC Public Health. 2015;15:193. doi:10.1186/s12889-015-1514-y
  • Carey IM, Critchley JA, DeWilde S, et al. Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. Diabetes Care. 2018;41(3):513–521. doi:10.2337/dc17-2131
  • Kobayashi D, Shimbo T, Noto H, et al. Low level of hemoglobin A1c and the increased incidence of herpes zoster: longitudinal study. Eur J Clin Microbiol. 2019;38(8):1539–1545. doi:10.1007/s10096-019-03584-1
  • Muller LM, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005;41(3):281–288. doi:10.1086/431587
  • Xiong Y, Ling QH, Han F, et al. An efficient gene selection method for microarray data based on LASSO and BPSO. BMC Bioinform. 2019;20(Suppl 22):715. doi:10.1186/s12859-019-3228-0
  • Ami R, Hatta W, Iijima K, et al. Factors associated with metachronous gastric cancer development after endoscopic submucosal dissection for early gastric cancer. J Clin Gastroenterol. 2017;51(6):494–499. doi:10.1097/MCG.0000000000000620
  • Munoz-Quiles C, Lopez-Lacort M, Ampudia-Blasco FJ, et al. Risk and impact of herpes zoster on patients with diabetes: a population-based study, 2009–2014. Hum Vaccin Immunother. 2017;13(11):2606–2611. doi:10.1080/21645515.2017.1368600
  • Kidd AC, McGettrick M, Tsim S, et al. Survival prediction in mesothelioma using a scalable Lasso regression model: instructions for use and initial performance using clinical predictors. BMJ Open Respir Res. 2018;5(1):e240. doi:10.1136/bmjresp-2017-000240
  • Kramer AA, Zimmerman JE. Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited. Crit Care Med. 2007;35(9):2052–2056. doi:10.1097/01.CCM.0000275267.64078.B0
  • Vickers AJ, Cronin AM, Elkin EB, et al. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak. 2008;8:53. doi:10.1186/1472-6947-8-53
  • Wang H, Zhang L, Liu Z, et al. Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram. Patient Prefer Adherence. 2018;12:1757–1765. doi:10.2147/PPA.S159293
  • Jiang F, Wei K, Lyu W, et al. Predicting risk of insulin resistance in a Chinese population with polycystic ovary syndrome: designing and testing a new predictive nomogram. Biomed Res Int. 2020;2020:1–9.
  • Chen HH, Lin CL, Yeh SY, et al. Short-term dipeptidyl peptidase-4 inhibitor use increases the risk of herpes zoster infection in Asian patients with diabetes. QJM. 2016;109(2):91–95. doi:10.1093/qjmed/hcv096
  • Guignard AP, Greenberg M, Lu C, et al. Risk of herpes zoster among diabetics: a matched cohort study in a US insurance claim database before introduction of vaccination, 1997–2006. Infection. 2014;42(4):729–735. doi:10.1007/s15010-014-0645-x
  • Yun H, Yang S, Chen L, et al. Risk of herpes zoster in autoimmune and inflammatory diseases: implications for vaccination. Arthritis Rheumatol. 2016;68(9):2328–2337. doi:10.1002/art.39670
  • Kawai K, Yawn BP. Risk factors for herpes zoster: a systematic review and meta-analysis. Mayo Clin Proc. 2017;92(12):1806–1821. doi:10.1016/j.mayocp.2017.10.009
  • Ogunjimi B, Buntinx F, Bartholomeeusen S, et al. Herpes zoster is associated with herpes simplex and other infections in under 60 year-olds. J Infect. 2015;70(2):171–177. doi:10.1016/j.jinf.2014.08.016
  • Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4(6):e4833. doi:10.1136/bmjopen-2014-004833
  • Madonna R, Balistreri CR, Geng YJ, et al. Diabetic microangiopathy: pathogenetic insights and novel therapeutic approaches. Vascul Pharmacol. 2017;90:1–7. doi:10.1016/j.vph.2017.01.004
  • Strain WD, Paldanius PM. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol. 2018;17(1):57. doi:10.1186/s12933-018-0703-2